The pathological mechanisms and novel therapeutics for Leber's hereditary optic neuropathy.

Bibliographic Details
Title: The pathological mechanisms and novel therapeutics for Leber's hereditary optic neuropathy.
Authors: Yi-Ping Yang, Shania Foustine, Yu-Jer Hsiao, En-Tung Tsai, Fu-Ting Tsai, Chia-Lin Wang, Yu-Ling Ko, Hsiao-Yun Tai, Yi-Ching Tsai, Chang-Hao Yang, Yun-Ju Fu, An-Guor Wang, Yueh Chien
Source: Journal of the Chinese Medical Association; Jun2023, Vol. 86 Issue 6, p539-541, 3p
Subject Terms: INDUCED pluripotent stem cells, RETINAL ganglion cells, RETINAL injuries, LEBER'S hereditary optic atrophy, NEUROPATHY, NADH dehydrogenase, REACTIVE oxygen species
Abstract: Optic neuropathies were estimated to affect 115 in 100,000 population in 2018. Leber's Hereditary Optic Neuropathy (LHON) as one of such optic neuropathy diseases that was first identified in 1871 and can be defined as a hereditary mitochondrial disease. LHON is associated with three mtDNA point mutations which are G11778A, T14484, and G3460A that affect the NADH dehydrogenase subunits of 4, 6, and 1, respectively. However, in most cases, only one point mutation is involved. Generally, in manifestation of the disease, there are no symptoms until the terminal dysfunction in the optic nerve is observed. Due to the mutations, nicotinamide adenine dinucleotide (NADH) dehydrogenase or complex I is absent and thus ATP production is stopped. This further causes the generation of reactive oxygen species and retina ganglion cells apoptosis. Aside from the mutations, there are several environmental factors such as smoking and alcohol consumption that can be pointed out as the risk factors of LHON. Nowadays, gene therapy has been intensively studied for LHON treatment. Disease models using human induced pluripotent stem cells (hiPSCs) have been utilized for LHON research. [ABSTRACT FROM AUTHOR]
Copyright of Journal of the Chinese Medical Association is the property of Wolters Kluwer UK and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Supplemental Index
More Details
ISSN:17264901
DOI:10.1097/JCMA.0000000000000927
Published in:Journal of the Chinese Medical Association
Language:English